Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

SurgePays (SURG) Cost of Revenue (2016 - 2025)

SurgePays has reported Cost of Revenue over the past 16 years, most recently at $18.6 million for Q4 2025.

  • For Q4 2025, Cost of Revenue fell 10.78% year-over-year to $18.6 million; the TTM value through Dec 2025 reached $67.6 million, down 10.18%, while the annual FY2025 figure was $67.6 million, 10.18% down from the prior year.
  • Cost of Revenue for Q4 2025 was $18.6 million at SurgePays, down from $21.3 million in the prior quarter.
  • Over five years, Cost of Revenue peaked at $34.3 million in Q3 2022 and troughed at $9.9 million in Q1 2021.
  • A 5-year average of $19.9 million and a median of $19.7 million in 2024 define the central range for Cost of Revenue.
  • Biggest five-year swings in Cost of Revenue: surged 171.08% in 2022 and later plummeted 46.78% in 2024.
  • Year by year, Cost of Revenue stood at $12.3 million in 2021, then surged by 138.96% to $29.5 million in 2022, then fell by 15.68% to $24.9 million in 2023, then fell by 16.27% to $20.8 million in 2024, then dropped by 10.78% to $18.6 million in 2025.
  • Business Quant data shows Cost of Revenue for SURG at $18.6 million in Q4 2025, $21.3 million in Q3 2025, and $14.2 million in Q2 2025.